-
1دورية أكاديمية
المؤلفون: Weiling Li, Xiaoling Zhang, Yunyi Du, Ying Zhang, Jing Lu, Wenqing Hu, Jun Zhao
المصدر: Biomarker Research, Vol 10, Iss 1, Pp 1-20 (2022)
مصطلحات موضوعية: HER2-targeted therapy, Gastric cancer, Gastric/gastroesophageal junction adenocarcinoma, Monoclonal antibody, Bispecific antibody, Antibody–drug conjugates, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2050-7771
-
2دورية أكاديمية
المؤلفون: Li, WeilingAff1, Aff2, Zhang, Xiaoling, Du, Yunyi, Zhang, YingAff1, Aff2, Lu, Jing, Hu, Wenqing, Zhao, JunAff1, IDs4036402200416x_cor7
المصدر: Biomarker Research. 10(1)
-
3دورية أكاديمية
المؤلفون: Haiping Jiang, Yulong Zheng, Jiong Qian, Chenyu Mao, Xin Xu, Ning Li, Cheng Xiao, Huan Wang, Lisong Teng, Hui Zhou, Shuyan Wang, Donglei Zhu, Bo Peng, Lin Shen, Nong Xu
المصدر: BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
مصطلحات موضوعية: Sintilimab, Capecitabine, Oxaliplatin, Gastric/gastroesophageal junction adenocarcinoma, Tumor mutation burden, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
4دورية أكاديمية
المؤلفون: Caiyun Nie, Huifang Lv, Yingjun Liu, Beibei Chen, Weifeng Xu, Jianzheng Wang, Xiaobing Chen
المصدر: Frontiers in Oncology, Vol 11 (2021)
مصطلحات موضوعية: gastric/gastroesophageal junction adenocarcinoma, sintilimab, immunotherapy, efficacy, Lauren classification, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
5دورية أكاديمية
المؤلفون: Jiang, Haiping, Zheng, Yulong, Qian, Jiong, Mao, Chenyu, Xu, Xin, Li, Ning, Xiao, Cheng, Wang, Huan, Teng, Lisong, Zhou, Hui, Wang, Shuyan, Zhu, Donglei, Peng, Bo, Shen, Lin, Xu, NongAff1
المصدر: BMC Cancer. 20(1)
-
6دورية أكاديمية
المؤلفون: Ian Chau, Nicolas Penel, Andres O. Soriano, Hendrik-Tobias Arkenau, Jennifer Cultrera, Rafael Santana-Davila, Emiliano Calvo, Christophe Le Tourneau, Lars Zender, Johanna C. Bendell, Gu Mi, Ling Gao, Samuel Clark McNeely, Joana M. Oliveira, David Ferry, Roy S. Herbst, Charles S. Fuchs
المصدر: Cancers, Vol 12, Iss 10, p 2985 (2020)
مصطلحات موضوعية: gastric/gastroesophageal junction adenocarcinoma, pembrolizumab, phase 1b, ramucirumab, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
7
المؤلفون: Andres O. Soriano, Nicolas Penel, Hendrik-Tobias Arkenau, Lars Zender, Ling Gao, Rafael Santana-Davila, Joana M Oliveira, Roy S. Herbst, Jennifer L. Cultrera, Ian Chau, Samuel McNeely, Johanna C. Bendell, Christophe Le Tourneau, Emiliano Calvo, Charles S. Fuchs, David Ferry, Gu Mi
المصدر: Cancers, Vol 12, Iss 2985, p 2985 (2020)
Cancers
Volume 12
Issue 10مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, ramucirumab, Pembrolizumab, lcsh:RC254-282, Article, Ramucirumab, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Clinical endpoint, 030212 general & internal medicine, phase 1b, Adverse effect, Antitumor activity, business.industry, Cancer, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, gastric/gastroesophageal junction adenocarcinoma, Tolerability, 030220 oncology & carcinogenesis, Adenocarcinoma, pembrolizumab, business
وصف الملف: application/pdf
-
8
المؤلفون: Yulong Zheng, Xin Xu, Jiong Qian, Lin Shen, Haiping Jiang, Chenyu Mao, Bo Peng, Nong Xu, Shuyan Wang, Hui Zhou, Donglei Zhu, Cheng Xiao, Ning Li, Lisong Teng, Huan Wang
المصدر: BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, Tumor mutation burden, Drug-Related Side Effects and Adverse Reactions, Gastroesophageal Junction Adenocarcinoma, Adenocarcinoma, Antibodies, Monoclonal, Humanized, Gastroenterology, lcsh:RC254-282, Severity of Illness Index, Capecitabine, 03 medical and health sciences, 0302 clinical medicine, Maintenance therapy, Stomach Neoplasms, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Genetics, medicine, Humans, Adverse effect, Aged, business.industry, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Sintilimab, Progression-Free Survival, Oxaliplatin, Clinical trial, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, Gastric/gastroesophageal junction adenocarcinoma, Esophagogastric Junction, business, Progressive disease, medicine.drug, Research Article, Follow-Up Studies
-
9دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
10دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.